Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	1.6	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.2	2.7	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	18.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	3.1	6.5	0.6	2.2	2.0	0.0	0.6	0.1	2.2	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0	0.0	0.0	0.0	0.1	0.2	16.5	56.0	2.5	0.0	0.0	7.0	0.0	1.1	0.0	11.5	0.7	0.4	0.5	0.0	6.3	3.1	2.3	0.1	0.0	0.0	0.2	0.0	0.0	2.5	0.0	1.1	19.0	0.0	0.0	1.8	0.3	0.8	0.6	59.6	69.3	0.7	1.5	64.7	12.2	0.7	5.6	0.6	10.4	0.0	1.2	0.0
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 121.8;Suprabasal keratinocytes: 239.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;EFO-21: 10.4;HaCaT: 10.3;HeLa: 17.3;MCF7: 14.9;SK-BR-3: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	5.6	0.4	0.0	10.4	0.0	0.0	10.3	1.1	0.1	0.0	0.0	2.6	0.0	17.3	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.9	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	1.6	7.1	0.0	0.9	5.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0											17.9	8.6	0.0	14.7	121.8	0.8	15.4	17.8	9.4	2.3	14.0	0.0	1.6	0.0	10.2	0.3	1.1	29.4	0.0	12.8	0.1	1.9	5.7	0.0	3.0	0.3	0.0	5.8	0.6	0.0	0.0	0.0	0.6	15.1	0.0	11.2	0.5	21.7	23.0	0.0	3.5	0.1	0.0	4.1	1.6	0.4	239.8	5.1	0.0	21.5	36.3
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Cell type enriched"	"Detected in some"	11	"Urothelial cells: 2979.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	100	"A-431: 216.9;HaCaT: 144.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1100000000	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	216.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	144.9	0.0	0.0	0.0	0.1	0.0	0.3	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.6	1.3	250.4	2.5	0.0	0.6	0.0	1.4	14.8	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	66.7	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	51.8	0.0	0.0	0.0	0.4	0.0	0.1	2.5	269.4	0.0	0.0	0.0	0.2	0.2	0.4	1.4	0.3	0.0	0.2	2979.9
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586921	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 439.2;tongue: 363.5"	"Group enriched"	"Detected in some"	11	"Basal keratinocytes: 31612.6;Suprabasal keratinocytes: 10207.3"	"Group enriched"	"Detected in many"	6	"cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 265.9;HBEC3-KT: 131.1;hTCEpi: 164.0;hTERT-HME1: 53.6;U-2197: 46.3"					"Not detected"	"Not detected"			"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		2200000000	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	0.2	0.1	0.2	0.2	0.2	0.2	23.1	0.2	0.2	27.0	0.2	0.2	0.2	0.1	0.3	0.2	69.3	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	7.6	0.2	2.1	0.1	0.2	30.8	0.3	1.0	439.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	4.6	0.2	363.5	47.6	0.2	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.9	0.0	131.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	164.0	0.2	53.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	46.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	999.3	31612.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	6.8	0.0	0.0	56.3	2.6	68.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1887.9	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	75.4	0.0	0.0	10207.3	2.1	0.0	0.2	106.7
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in many"	8	"Basal glandular cells: 10709.5;Urothelial cells: 6883.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 653.9;SiHa: 272.2"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		750000000	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.5	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	66.1	0.0	67.6	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	653.9	0.0	50.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	24.8	0.0	0.0	272.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7	20.8	7.4	0.0	10709.5	124.0	0.0	0.0	0.0	112.4	563.0	34.9	0.0	2.0	0.0	285.1	0.3	2.9	0.0	0.0	180.6	118.1	9.3	924.1	3.5	0.0	3.5	19.1	1.7	0.0	0.0	1.3	2.0	7.9	10.1	11.8	0.1	0.0	1050.1	0.0	199.8	0.0	0.0	0.0	5.7	0.4	0.2	108.7	4.8	0.5	0.6	6883.0
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 93.8;Suprabasal keratinocytes: 132.4;Urothelial cells: 329.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 470.1"									"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		NA	NA		7200000000	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavorable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.9	0.0	113.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	470.1	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.7	93.8	0.0	0.0	0.0	2.7	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	132.4	0.0	0.0	0.0	329.0
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell type enhanced"	"Detected in some"	13	"Ductal cells: 70.7;Pancreatic endocrine cells: 32.8;Suprabasal keratinocytes: 32.6;Syncytiotrophoblasts: 48.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 44.6;MCF7: 63.7;SK-BR-3: 29.5;U-2 OS: 41.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		No	No		290000000	"Intermediate filaments"		"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavorable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.6	15.0	0.0	0.0	0.0	0.0	12.5	0.6	0.4	3.5	1.0	1.0	19.6	0.0	22.0	0.5	23.2	22.3	0.0	0.3	1.2	0.0	0.0	0.0	23.4	0.5	2.4	0.0	0.0	0.2	2.7	0.8	5.4	16.4	5.3	0.0	0.0	0.0	1.2	63.7	0.0	0.0	0.0	13.0	2.3	0.0	18.4	0.6	20.1	8.0	5.7	0.3	11.3	29.5	0.2	1.3	5.5	0.2	3.0	0.0	41.3	0.0	16.0	0.0	0.0	0.1	4.2	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.5	5.6	0.0	0.3	10.2	6.7	1.2	10.4	0.0	19.7	0.0	70.7	0.6	0.0	0.0	0.0	17.4	0.6	0.7	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	32.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	32.6	48.7	0.0	0.0	7.8
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913012-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.7"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 26.9;Early spermatids: 68.8;Late spermatids: 86.3;Rod photoreceptor cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	23	"HEK 293: 292.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA			"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	1.5	18.9	20.3	2.0	24.2	1.3	1.3	10.9	87.6	9.7	2.0	5.6	0.0	1.3	3.8	1.3	4.7	1.3	1.4	1.3	36.1	25.0	2.2	1.2	1.3	1.3	52.2	22.4	2.0	2.5	1.2	3.3	1.4	144.7	2.5	1.9	3.4	1.3	26.9	1.9	1.3	1.5	3.3	26.7	1.3	1.5	12.4	4.9	0.0	1.3	0.0	1.6	1.3	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	292.9	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	24.2	10.9	71.9	36.1	25.0	52.2	22.4	144.7	4.9	0.0	0.0	0.0	0.1	1.1	26.9	2.0	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	68.8	0.6	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	19.1	3.4	0.0	0.0	86.3	0.9	0.0	1.7	0.0	0.0	20.8	0.0	0.0	4.2	0.4	46.9	0.0	1.3	2.2	1.3	0.3	0.0	0.0	0.0	0.3
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677397	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.9"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 191.0;Endothelial cells: 67.1;Sertoli cells: 103.5;Smooth muscle cells: 44.2"	"Group enriched"	"Detected in all"	6	"glioma: 147.0;melanoma: 101.4;testis cancer: 34.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 92.5;HUVEC TERT2: 46.8;LHCN-M2: 74.7;RH-30: 76.5;SuSa: 52.8;WM-115: 36.1"					"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	22.1	4.2	6.2	7.1	7.6	0.4	13.8	6.0	13.3	16.9	5.9	13.0	7.5	3.1	23.4	12.3	10.0	12.5	8.9	77.9	6.5	5.1	15.7	4.5	16.0	4.2	8.2	5.1	13.2	2.2	7.5	5.6	8.9	12.8	14.6	4.0	12.2	3.8	20.0	25.3	3.2	4.9	16.1	12.0	26.8	4.2	5.3	6.2	0.4	8.0	16.8	3.5	12.7	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.5	19.7	0.2	5.1	0.0	22.3	17.6	0.3	0.5	14.6	0.2	0.0	5.3	2.1	0.0	0.4	9.3	0.0	0.2	0.0	0.1	0.1	1.3	6.6	0.8	0.0	5.5	4.3	0.0	0.8	0.0	0.7	46.8	0.0	0.6	0.0	74.7	0.6	0.0	0.0	15.0	0.8	12.8	0.1	76.5	0.0	0.0	0.0	0.2	14.9	0.5	0.6	17.2	52.8	0.2	0.1	33.8	0.1	5.2	0.6	1.2	0.0	3.3	0.0	2.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.6	6.0	6.3	6.5	5.1	8.2	5.1	12.8	6.2	0.0	7.9	0.0	0.4	2.2	0.3	191.0	0.0	0.0	1.2	17.4	0.0	0.2	0.0	1.4	0.4	67.1	0.0	0.0	0.0	1.9	14.4	0.4	0.0	0.0	1.5	0.0	0.0	23.4	0.6	0.0	7.5	1.1	1.7	1.8	0.0	13.2	0.4	0.0	3.9	0.0	1.1	103.5	44.2	0.5	3.1	2.0	0.1	0.0	0.0	0.3
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.3	25.6	33.1	36.3	18.1	19.6	29.6	15.5	25.5	7.6	16.2	15.3	27.2	37.6	25.0	6.9	19.4	24.1	28.5	13.0	7.3	17.7	16.9	10.3	23.5	13.2	26.3	25.0	20.2	20.7	29.9	27.9	24.7	13.8	12.1	28.9	25.0	7.2	15.8	12.2	6.6	7.3	5.5	10.3	29.3	25.5	24.1	10.7	6.4	16.4	20.2	7.4	23.6	23.3	16.7	19.6	28.4	22.1	10.8	20.3	9.1	19.5	16.6	18.2	23.4	18.4	14.5	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4	62.5	47.1	47.1	45.8	56.3	93.5	116.8	50.9	41.5	45.5	54.1	58.9	19.9	41.4	32.7	16.4	64.5	53.5	0.0	28.7	23.4	57.5	66.5	46.2	90.1	46.6	73.1	64.9	65.1	78.4	15.1	78.9	53.7	57.3	31.5	47.8	99.2	29.4	20.1	87.0	45.1	78.2	77.6	80.4	73.2	30.2	50.8	22.0	50.7	29.6	32.0
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.7	9.3	18.5	11.1	12.4	14.1	12.0	14.1	13.0	15.8	16.5	9.9	17.1	9.4	16.8	13.4	19.5	18.8	18.0	10.7	21.7	3.3	13.1	6.9	19.4	8.4	10.9	6.8	2.1	11.6	11.1	12.4	15.0	12.6	18.0	7.5	11.5	6.9	17.0	4.8	7.8	5.9	9.3	9.0	10.9	7.5	28.2	3.8	14.0	46.8	9.0	5.9	21.1	12.2	18.1	14.6	9.1	6.2	16.8	13.5	12.1	17.2	14.7	3.8	3.2	6.4	5.6	6.7	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2	38.7	52.6	24.5	42.6	42.9	83.6	41.1	40.8	45.5	39.8	66.3	84.4	37.5	10.0	51.4	2.1	51.2	79.8	70.0	52.5	29.4	35.1	52.3	15.1	32.6	20.4	62.0	42.5	51.0	34.3	2.9	50.3	29.0	30.4	41.5	55.9	64.3	62.0	87.7	45.3	22.4	151.6	38.8	29.8	35.8	18.8	45.8	31.2	21.0	50.9	118.4
SESTD1	"DKFZp434O0515, Solo"	ENSG00000187231	"SEC14 and spectrin domain containing 1"	Q86VW0	2	179101692-179264790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 4.3;dendritic cells: 1.1;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058236, HPA077408"	Approved		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA058236: AB_2732619, HPA077408: AB_2732344"	"unprognostic (2.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (9.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"unprognostic (9.21e-2)"	"prognostic favorable (2.78e-11)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-2)"	23.6	5.0	11.2	6.5	11.3	8.1	32.1	10.3	17.0	12.7	10.0	15.8	9.1	4.3	11.1	7.9	8.8	6.4	12.0	9.6	13.5	9.9	12.7	6.5	16.9	6.2	14.4	9.4	9.0	6.2	8.9	7.2	12.5	12.7	9.4	7.6	7.6	16.6	9.2	5.7	7.0	8.7	22.5	21.0	6.5	9.1	15.9	11.5	3.7	6.1	6.2	9.1	19.9	23.7	4.3	1.1	0.2	3.7	0.6	0.1	0.6	0.0	1.2	15.5	2.8	28.2	12.3	8.2	5.4	2.2	2.3	3.9	2.7	3.6	2.6	7.2	5.1	2.8	2.5	6.5	3.0	4.1	1.9	1.8	3.2	7.0	7.2	2.2	1.7	1.4	9.1	1.3	3.5	8.8	5.4	9.1	2.7	0.5	1.4	3.8	1.8	4.1	0.2	4.0	2.7	1.6	6.0	10.2	1.7	6.2	13.7	3.4	5.8	4.7	2.1	1.5	12.0	0.3	2.0	15.9	7.6	3.9	3.8	2.7	0.8	0.0	6.4	3.8	0.7	2.2	0.0	2.1	0.0	0.0	1.8	0.0	2.7	0.1	0.0	1.1	4.3	0.1	0.0	0.2	0.6	3.7	0.0	0.1	0.6	11.2	11.3	10.3	16.1	13.5	9.9	14.4	9.4	12.7	11.5	101.3	25.1	16.2	20.3	8.8	27.5	13.3	12.7	24.1	21.6	12.2	17.7	7.6	14.9	23.4	6.1	21.5	17.0	0.0	23.7	53.0	41.0	56.1	0.0	8.1	11.3	284.4	24.0	19.0	24.6	6.0	11.2	24.9	13.5	1.0	5.8	32.4	30.0	14.0	28.7	30.6	10.6	19.4	24.5	31.7	61.3	8.8	15.1	4.3	6.4	58.7
SYCE1L	MRP2	ENSG00000205078	"Synaptonemal complex central element protein 1 like"	A8MT33	16	77199397-77213215	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.0;U-698: 10.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062464, HPA066691"			Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA062464: , HPA066691: AB_2685702"	"unprognostic (5.54e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (9.27e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.73e-2)"	3.5	3.4	2.8	4.1	2.7	2.9	3.7	5.2	2.4	8.7	5.0	0.4	11.5	2.1	7.8	7.6	4.4	2.8	1.8	7.0	2.8	3.0	4.3	1.4	1.9	4.5	2.1	1.4	8.5	2.7	2.3	2.3	1.6	1.5	6.6	1.6	5.4	11.1	8.7	1.7	4.3	4.6	2.0	2.5	4.2	2.3	22.4	0.4	6.4	8.0	2.0	2.4	2.3	4.4	3.5	12.2	12.0	2.2	2.7	10.5	3.4	2.8	1.1	2.8	1.3	0.3	0.0	0.5	0.8	0.3	0.5	0.9	0.6	5.7	1.9	3.8	0.6	0.2	4.1	0.2	0.0	0.3	1.7	13.0	0.4	1.0	0.0	1.9	0.9	1.2	0.1	0.4	0.1	0.3	0.5	2.0	2.6	0.7	0.2	0.3	4.2	0.7	1.3	1.9	0.4	4.5	6.7	0.7	0.6	2.5	0.8	2.9	3.4	0.4	0.3	0.0	0.3	0.1	1.2	6.5	0.4	6.5	0.9	0.2	5.5	2.1	10.1	2.8	0.7	0.2	4.0	1.3	12.0	6.1	2.2	7.3	3.5	7.9	8.4	1.6	2.6	8.7	8.0	1.3	2.7	1.6	12.2	10.5	3.4	2.8	2.7	5.2	2.2	2.8	3.0	2.1	1.4	1.5	0.4	3.0	3.0	6.0	9.6	15.3	3.7	2.0	30.6	1.4	5.7	26.2	9.8	5.2	13.3	23.2	19.5	7.5	6.9	0.0	24.3	3.8	9.0	15.6	1.1	10.6	2.1	1.6	21.6	16.5	13.5	35.7	12.7	3.1	18.6	2.8	30.3	14.0	19.1	22.4	6.3	17.9	35.5	6.5	4.2	34.7	8.1	14.9	2.4	13.4	29.9	5.7
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715822-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	10.9	10.6	14.5	13.4	17.6	3.5	17.1	13.7	14.0	18.2	10.9	12.8	12.7	9.1	14.9	14.1	11.9	15.7	8.0	13.4	14.6	14.0	13.2	16.4	8.9	13.0	13.5	9.3	18.5	16.6	15.6	14.6	12.5	12.9	13.5	10.8	9.2	13.1	14.7	33.3	14.7	8.5	12.8	20.4	10.3	11.2	13.3	12.0	11.7	11.5	15.1	14.0	11.4	13.6	11.5	11.3	8.6	11.7	15.0	14.9	10.5	9.9	7.5	8.9	4.5	14.4	7.3	7.8	13.7	6.8	17.8	10.7	9.4	2.8	18.4	7.4	9.2	19.5	5.8	19.9	13.5	18.0	15.6	15.7	17.7	3.4	5.3	12.6	13.4	4.3	6.5	13.8	25.9	15.9	7.7	7.3	14.5	18.9	2.3	9.6	4.7	11.9	8.1	18.7	13.1	14.4	11.0	18.9	8.3	8.7	2.8	5.8	4.1	11.6	6.2	11.5	15.3	5.6	7.3	7.0	8.7	9.6	8.8	18.4	6.6	11.7	14.6	11.2	15.3	8.8	5.9	10.3	8.6	12.5	11.7	13.3	11.5	10.3	11.8	11.3	11.0	14.9	13.2	0.2	15.0	11.3	9.6	9.3	10.5	14.5	17.6	13.7	14.0	14.6	14.0	13.5	9.3	12.9	12.0	8.9	1.6	4.5	2.5	1.0	4.1	2.8	2.5	4.0	7.9	0.0	0.0	3.1	0.0	2.9	0.4	2.1	1.3	0.0	3.6	2.0	1.7	1.5	6.9	2.4	1.2	4.8	1.2	3.7	1.2	0.0	3.7	1.6	1.7	8.2	1.3	3.3	3.2	1.1	2.5	2.5	3.1	0.0	0.8	7.2	8.7	1.4	1.1	2.2	2.3	1.7